Virpax Pharmaceuticals (VRPX) Short Interest Ratio & Short Volume → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free VRPX Stock Alerts $0.78 -1.51 (-65.94%) (As of 05/15/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Virpax Pharmaceuticals Short Interest DataCurrent Short Volume7,900 sharesPrevious Short Volume14,800 sharesChange Vs. Previous Month-46.62%Dollar Volume Sold Short$21,409.00Short Interest Ratio / Days to Cover0.3Last Record DateApril 30, 2024Outstanding Shares1,170,000 sharesFloat Size870,000 sharesShort Percent of Float0.91%Today's Trading Volume2,698,881 sharesAverage Trading Volume49,835 sharesToday's Volume Vs. Average5,416% Short Selling Virpax Pharmaceuticals ? Sign up to receive the latest short interest report for Virpax Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatVRPX Short Interest Over TimeVRPX Days to Cover Over TimeVRPX Percentage of Float Shorted Over Time Ad Market Moving TrendsTop 5 AI Stocks to Buy for 20245 Best AI Stocks to Invest In Investors are getting very rich in AI stocks right now. Wall Street legend is giving away the name and ticker of the little-known AI stock Wall Street is currently buying hand-over-fist.Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In" Virpax Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20247,900 shares $21,409.00 -46.6%0.9%0.3 $2.71 4/15/202414,800 shares $52,248.44 -50.3%1.7%0.6 $3.53 3/31/202429,800 shares $126,983.76 +24.7%3.4%1.3 $4.26 3/15/202423,900 shares $99,663.00 +119.3%2.8%1 $4.17 2/29/202410,900 shares $33,266.80 -82.5%1.3%0.3 $3.05 2/15/202462,400 shares $22,938.24 -12.2%0.7%0.2 $0.37 Get the Latest News and Ratings for VRPX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Virpax Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/202471,100 shares $23,391.90 +38.1%0.8%0.2 $0.33 1/15/202451,500 shares $13,750.50 -44.1%0.6%0.2 $0.27 12/31/202392,100 shares $29,481.30 +479.3%1.1%0.3 $0.32 12/15/202315,900 shares $6,224.85 -58.4%0.2%0.1 $0.39 11/30/202338,200 shares $15,272.36 -30.3%0.4%0.7 $0.40 11/15/202354,800 shares $40,661.60 -8.8%0.6%2.1 $0.74 10/31/202360,100 shares $42,983.52 +110.1%0.7%2.4 $0.72 10/15/202328,600 shares $23,457.72 -40.3%0.3%1.1 $0.82 9/30/202347,900 shares $38,315.21 +197.5%0.6%2.3 $0.80 9/15/202316,100 shares $12,702.90 -37.6%0.2%0.7 $0.79 8/31/202325,800 shares $22,188.00 -22.8%0.3%0.8 $0.86 8/15/202333,400 shares $29,893.00 -20.1%0.4%1 $0.90 7/31/202341,800 shares $37,202.00 +1.7%0.5%1.3 $0.89 7/15/202341,100 shares $40,278.00 -48.1%0.5%1.3 $0.98 6/30/202379,200 shares $85,536.00 +56.8%0.9%2.6 $1.08 6/15/202350,500 shares $46,460.00 -35.2%0.6%1.8 $0.92 5/31/202377,900 shares $61,143.71 -26.1%0.9%4.2 $0.78 5/15/2023105,400 shares $90,654.54 +22.3%1.2%6.1 $0.86 4/30/202386,200 shares $61,245.10 +2.9%1.0%4.1 $0.71 4/15/202383,800 shares $64,291.36 -7.7%1.0%2.1 $0.77 3/31/202390,800 shares $71,278.00 +7.3%1.0%2.3 $0.79 3/15/202384,600 shares $67,680.00 +6.8%1.0%1.8 $0.80 2/28/202379,200 shares $74,677.68 -40.4%0.9%1.6 $0.94 2/15/2023132,900 shares $145,339.44 +285.2%1.6%2.6 $1.09 1/31/202334,500 shares $34,148.10 +1.8%0.4%0.7 $0.99 1/15/202333,900 shares $28,137.00 -18.9%0.4%0.9 $0.83 12/30/202241,800 shares $26,012.14 -51.1%0.5%1 $0.62 12/15/202285,400 shares $68,320.00 +100.9%1.0%2.3 $0.80 11/30/202242,500 shares $35,700.00 +21.1%0.5%1.2 $0.84 11/15/202235,100 shares $30,105.27 +19.0%0.4%1 $0.86 10/31/202229,500 shares $31,565.00 +16.6%0.3%0.7 $1.07 10/15/202225,300 shares $27,071.00 -39.3%0.3%0.5 $1.07 9/30/202241,700 shares $49,623.00 +37.6%0.5%0.9 $1.19 9/15/202230,300 shares $39,693.00 +5.6%0.4%0.6 $1.31The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (Ad)Nanoviricides Technology Will Transform The Way Viruses & Their Variants Are Treated Worldwide And This Company Is At The Forefront!See how with its ongoing expansion and development VRPX Short Interest - Frequently Asked Questions What is Virpax Pharmaceuticals' current short interest? Short interest is the volume of Virpax Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 7,900 shares of VRPX short. 0.91% of Virpax Pharmaceuticals' shares are currently sold short. Learn More on Virpax Pharmaceuticals' current short interest. What is a good short interest percentage for Virpax Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.91% of Virpax Pharmaceuticals' floating shares are currently sold short. Is Virpax Pharmaceuticals' short interest increasing or decreasing? Virpax Pharmaceuticals saw a drop in short interest during the month of April. As of April 30th, there was short interest totaling 7,900 shares, a drop of 46.6% from the previous total of 14,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Virpax Pharmaceuticals' float size? Virpax Pharmaceuticals currently has issued a total of 1,170,000 shares. Some of Virpax Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Virpax Pharmaceuticals currently has a public float of 870,000 shares. How does Virpax Pharmaceuticals' short interest compare to its competitors? 0.91% of Virpax Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Virpax Pharmaceuticals: Agile Therapeutics, Inc. (12.68%), Mustang Bio, Inc. (0.91%), 60 Degrees Pharmaceuticals, Inc. (1.31%), Onconetix, Inc. (0.31%), Biophytis S.A. (2.62%), CohBar, Inc. (0.59%), Notable Labs, Ltd. (0.08%), Aravive, Inc. (1.81%), Sonoma Pharmaceuticals, Inc. (0.30%), Revelation Biosciences, Inc. (1.09%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Virpax Pharmaceuticals stock? Short selling VRPX is an investing strategy that aims to generate trading profit from Virpax Pharmaceuticals as its price is falling. VRPX shares are trading down $1.51 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Virpax Pharmaceuticals? A short squeeze for Virpax Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of VRPX, which in turn drives the price of the stock up even further. How often is Virpax Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VRPX, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: AGRX Short Squeeze MBIO Short Squeeze SXTP Short Squeeze ONCO Short Squeeze BPTS Short Squeeze CWBR Short Squeeze NTBL Short Squeeze ARAV Short Squeeze SNOA Short Squeeze REVB Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VRPX) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersAmazon's betting big on this unknown AI companyManward PressThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market AlertsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCharles Payne Demystifies OptionsUnstoppable Prosperity